Nobel laureate; Director & Professor, Center for iPS Cell Research and Application, Kyoto University
Professor Shinya Yamanaka is most recognized for his discovery of induced pluripotent stem cells (iPSC), which are differentiated cells that have been reprogrammed to the pluripotent state. He is Director of the Center for iPS Cell Research and Application (CiRA), which was founded in 2008 in response to his discovery at Kyoto University, and Senior Investigator at the Gladstone Institutes.
Since his breakthrough finding, he has been the recipient of many prestigious awards including the Albert Lasker Basic Medical Research Award, the 100th Imperial Prize and Japan Academy Prize, and the Wolf Prize in Medicine. The significance of iPSC was culminated with Dr. Yamanaka being awarded the Nobel Prize in 2012.
Professor Yamanaka also serves as a foreign associate of the NAS, an international member of the NAM, fellow of the AACR, and member of EMBO, Pontifical Academy of Sciences, and the Japan Academy.
The keynote speech at 2016 WAFSF will be given by Dr. Shinya Yamanaka, who will share his visions for the future of regenerative medicine. Dr. Yamanaka received the Nobel Prize in Physiology or Medicine for his discovery of induced Pluripotent Stem (iPS) cells, which has rapidly accelerated the development of regenerative medicine.
The world’s renowned visionaries in innovative healthcare technologies such as Nobel laureate Dr. Shinya Yamanaka and Dr. Daniel Kraft will discuss the future of healthcare and medicine, moderated by the New York Stem Cell Foundation’s CEO, Ms. Susan Solomon.